Hormonal growth promotants

In addition to the standard labelling requirements, labels for hormonal growth promotants (HGPs) must also carry the following information.

The following statement must appear immediately under the heading of ‘Active constituents’:

This product contains a palpable marker.

The following statement must appear on the label following the above statement:

This product must only be supplied in accordance with Division 4.2 of the Agvet Code Regulations (Supply of Hormonal Growth Promotants).

The following statement must appear under the ‘Directions for use’ heading:

To be used ONLY in accordance with the instructions on this label unless authorised under appropriate legislation.

1. Restraints

All products must carry the following statements under the ‘Restraints’ heading:

DO NOT USE in any animal other than [delete whichever does not apply: steers/heifers/steers and heifers] producing beef for human consumption.
DO NOT USE more than one implant of any type concurrently per [steer/heifer/steer or heifer].
DO NOT implant sooner than [x] days after the last implant.
DO NOT implant this product in any site other than beneath the skin in the middle third of the back of the ear.
DO NOT USE this product on HGP-free accredited cattle. It is a breach of Department of Agriculture accreditation conditions to use this product on HGP-free accredited cattle or to possess this product on any HGP-free accredited property (except for feedlots with flexible accreditation). Treated animals must be identified as having received a hormonal implant by use of an approved ear punch.

When use in heifers is approved, this additional statement is required:

[DO NOT USE in heifers that are producing, or may in the future produce, milk that may be used or processed for human consumption.]

2. Precautions

The following statements must appear under the ‘Precautions’ heading:

Implanting cattle under 6 weeks of age is NOT recommended.
Implanting cattle intended for breeding is NOT recommended as they may experience decreased fertility.
Growth responses may vary widely for nutritional or other reasons. Improved performance may be noted only when conditions are favourable for good growth.
[Preputial/vaginal] and rectal prolapse, increased bulling activity, high tailheads, sunken loins, ventral oedema and udder development may occur as side effects of treatment. [Delete whichever does not apply]
To help avoid abscess formation at the site of the implant, the surface of the ear should be thoroughly cleaned and disinfected before implantation.

When the product contains trenbolone, the following alternative statement is required (3 months for grass-fed or 6 months for lot-fed beef):

Implanting cattle under [3 months for grass fed/6 months for let fed] of age is NOT recommended.

3. Administration

The following statements must appear under the ‘Dosage and administration’ heading:

READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
Approved implantation technique is fully described in the enclosed leaflet.
Cattle implanted with this product must be individually identified with an approved ear punch mark.

4. Disposal

The following statements must appear under the ‘Disposal’ heading:

DO NOT dispose of unused implants in any way other than surrender to an approved retailer or wholesaler.
Dispose of empty cartridges by wrapping with paper and putting in garbage.
Discarded needles should immediately be placed in a designated ‘sharps’ container.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.